The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT04217291

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Suzhou Yabao Pharmaceutical R&D Co., Ltd. (from the registry)
Registry
  • NCT NCT04217291
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04217291. Randomized; quadruple masking; primary purpose treatment. Start 2019-12-10 (actual); primary completion 2021-07-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
SY-004
Intervention (Other)
SY-004 matching placebo
Lead sponsor
Suzhou Yabao Pharmaceutical R&D Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct04217291
Content hash
4d40d65ee03ca5704d1fd9200c5e9737eac8e979619691db02e3a3f92f7713ef